Home / Market News / $MRK
benzinga Corporate Catalyst Impact 55/100 ● positive

JP Morgan Maintains Overweight on Merck & Co, Raises Price Target to $165

Oct 5, 2026, 4:00 PM UTC · Primary ticker $MRK

JP Morgan's analyst Chris Schott has reiterated an Overweight rating on Merck & Co and increased its price target from $150 to $165. This indicates a continued positive outlook for the company's stock, suggesting potential upside for investors.

JP Morgan analyst Chris Schott has maintained an 'Overweight' rating on Merck & Co (MRK) and raised the price target from $150 to $165. This action signals continued confidence from a major investment bank in Merck's future performance and valuation. For traders, this could lead to short-term positive sentiment and potentially increased buying activity for MRK stock, as the higher price target suggests further upside. Long-term, it reinforces the investment thesis for existing shareholders and might attract new investors. The key opportunity for traders lies in capitalizing on this positive analyst sentiment, though the actual market impact will depend on broader market conditions and other company-specific news.

$MRK positive Price target increase and maintained 'Overweight' rating
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.